- In August 2023, Padagis LLC, a leading provider of specialty pharmaceuticals, introduced the first over-the-counter (OTC) Naloxone HCl Nasal Spray in the U.S. This groundbreaking product is designed to quickly reverse the life-threatening effects of opioid overdoses, making it more accessible to the public
- In March 2023, Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd, launched additional strengths of the generic version of Revlimid® (lenalidomide capsules) in 2.5 mg and 20 mg doses in the U.S., aimed at expanding the company’s product portfolio
- In January 2023, Viatris Inc. a global healthcare company, announced the completion of its acquisitions of Oyster Point Pharma and Famy Life Sciences, marking the creation of its new Viatris Eye Care Division. This acquisition is expected to support the company's business expansion efforts
- In November 2021, Amcyte Pharma, a Seattle-based innovative pharmaceutical company, announced the U.S. launch of Nasitrol nasal spray, specifically formulated for sinus irrigation. This product aims to provide relief for sinus congestion and improve nasal health through routine use
- In October 2021, Cipla, Inc. launched Naselin, an antiviral nasal spray designed to protect against respiratory tract infections caused by coronaviruses. This product was developed to offer an additional layer of defense against viral infections, particularly during the COVID-19 pandemic
Frequently Asked Questions
The market is segmented based on Segmentation By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/Saline Nasal Spray, and Others), Container Design (Pump Bottles and Pressurized Canisters), Dosage Form (Multi Dose, Unit/Single Dose, and Bi Dose), Therapeutic Class (Antihistamine, Nasal Steroid, Mast Cell Inhibitor, and Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, and Others), Prescription/Availability (Over The Counter and Prescribed), End User (Home Care Settings, Hospitals, Clinics, and Community Health Care) – Industry Trends and Forecast to 2031
.
The Global Nasal Spray Market size was valued at USD 24.15 USD Billion in 2023.
The Global Nasal Spray Market is projected to grow at a CAGR of 6.7% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
